Andrew Huberman· PhD
They went on to show several years later that blood from umbilical cords, I'm not making this up, blood from umbilical cords can do the same and this is the basis of a biotech company.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
They went on to show several years later that blood from umbilical cords, I'm not making this up, blood from umbilical cords can do the same and this is the basis of a biotech company.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.